PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsVivax malaria
MeSH D016780 - vivax malaria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008288:Malaria
43 Companies
17 Drugs
$
Success rate
D016780: 
Vivax malaria
9 Companies
4 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novast LaboratoriesPrimaquine Primaquine  2016-06-23   
RocheMefloquine Lariam  1989-05-02   
SandozMefloquine Mefloquine  2002-02-20   
SanofiChloroquine, Primaquine Aralen W/ Primaquine  1982-01-01   
Primaquine Primaquine  1982-01-01   
Barr PharmaceuticalsMefloquine Mefloquine  2003-12-29   
AlvogenPrimaquine Primaquine  2014-02-03   
Hikma PharmaceuticalsMefloquine Mefloquine  2004-10-01   
Bayshore PharmaceuticalsPrimaquine Primaquine  2014-02-25   
Clinical Trials
Historical Success Rate
Phase 1
64%
7/11
Phase 2
82%
9/11
Phase 3
67%
10/15
Approved: 3Overall Success rate: 35%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Halofantrine,
Artemisinin,
Piperaquine,
Sodium lactate,
Microcrystalline cellulose,
Arm1,
Trinessa,
Arm2
Sanofi
Chloroquine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use